CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.48%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.8B
AUM Growth
+$630M
(+4.4%)
Cap. Flow
-$386M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
926
New
50
Increased
255
Reduced
457
Closed
57
Top Buys
| 1 |
Mercado Libre
MELI
|
+$41.1M |
| 2 |
Darling Ingredients
DAR
|
+$37M |
| 3 |
Johnson & Johnson
JNJ
|
+$34.5M |
| 4 |
Veru
VERU
|
+$34M |
| 5 |
MetLife
MET
|
+$31.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$46.7M |
| 2 |
Nike
NKE
|
+$42.5M |
| 3 |
Illinois Tool Works
ITW
|
+$37M |
| 4 |
Gilead Sciences
GILD
|
+$32.3M |
| 5 |
Merck
MRK
|
+$30.3M |
Sector Composition
| 1 | Healthcare | 33.31% |
| 2 | Technology | 22.85% |
| 3 | Financials | 10.04% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Industrials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Dell
DELL
$84.3B
| $5.85M | 0.04% |
145,362
-4,649
| -3% | -$187K |
|
352
Legend Biotech
LEGN
$6.19B
| $5.79M | 0.04% |
116,026
| – | – |
|
353
Valero Energy
VLO
$48.2B
| $5.78M | 0.04% |
45,574
-2,571
| -5% | -$326K |
|
354
Roper Technologies
ROP
$54.8B
| $5.71M | 0.04% |
13,206
-1,213
| -8% | -$524K |
|
355
West Pharmaceutical
WST
$18.1B
| $5.66M | 0.04% |
24,056
-1,449
| -6% | -$341K |
|
356
Akamai
AKAM
$11.1B
| $5.64M | 0.04% |
66,898
+8,397
| +14% | +$708K |
|
357
Motorola Solutions
MSI
$80.4B
| $5.48M | 0.04% |
21,259
-11,580
| -35% | -$2.98M |
|
358
Fidelity National Information Services
FIS
$35B
| $5.35M | 0.04% |
78,865
-13,724
| -15% | -$931K |
|
359
McKesson
MCK
$87.4B
| $5.33M | 0.04% |
14,200
-2,179
| -13% | -$817K |
|
360
Insulet
PODD
$23.9B
| $5.29M | 0.04% |
17,986
-39,670
| -69% | -$11.7M |
|
361
Scotiabank
BNS
$79.5B
| $5.29M | 0.04% |
108,113
-16,928
| -14% | -$829K |
|
362
International Flavors & Fragrances
IFF
$16.4B
| $5.28M | 0.04% |
50,346
+3,063
| +6% | +$321K |
|
363
Avnet
AVT
$4.46B
| $5.27M | 0.04% |
126,771
-99,833
| -44% | -$4.15M |
|
364
Karyopharm Therapeutics
KPTI
$55.3M
| $5.22M | 0.04% |
102,335
+13,333
| +15% | +$680K |
|
365
Amphenol
APH
$146B
| $5.17M | 0.03% |
135,690
-14,000
| -9% | -$533K |
|
366
Carrier Global
CARR
$54.8B
| $5.16M | 0.03% |
125,145
-13,040
| -9% | -$538K |
|
367
DuPont de Nemours
DD
$32.1B
| $5.14M | 0.03% |
74,827
-1,310
| -2% | -$89.9K |
|
368
Charter Communications
CHTR
$35.6B
| $5.1M | 0.03% |
15,047
-7,693
| -34% | -$2.61M |
|
369
IDEAYA Biosciences
IDYA
$2.19B
| $5.09M | 0.03% |
280,317
+25,000
| +10% | +$454K |
|
370
Gartner
IT
$17.8B
| $5.07M | 0.03% |
15,082
-1,706
| -10% | -$573K |
|
371
PACCAR
PCAR
$51.5B
| $5.06M | 0.03% |
76,725
-21,893
| -22% | -$1.44M |
|
372
Voya Financial
VOYA
$7.25B
| $5M | 0.03% |
+81,250
| New | +$5M |
|
373
W.P. Carey
WPC
$14.8B
| $5M | 0.03% |
65,261
-72,184
| -53% | -$5.52M |
|
374
Twist Bioscience
TWST
$1.49B
| $4.98M | 0.03% |
209,360
+106,000
| +103% | +$2.52M |
|
375
Archer Daniels Midland
ADM
$28.9B
| $4.94M | 0.03% |
53,172
-2,877
| -5% | -$267K |
|